Analysis of L-LA on gp120 protein conformation and rCD4 binding. by Muriel Aldunate (22411177)

Simulation Results Plot of the SBW System Response: (a) Step response curve of the SBW system; (b) Sine response curve of the SBW system; (c) Steady state error curve of the SBW sy... by Honglei Pang (22693724)

Spatial distribution of change rate of tetanus toxoid vaccination status from 2006 to 2019. by Md. Bony Amin (11462680)

Proportion of time spent in the Start Room or Avoidance Room or showing a behaviour (Stimulus Contact) presented across stimuli and separately for piglets and gilts. by Sara Hintze (3216885)

TRPC channels augment the presynaptic Ca²⁺-rise upon HFS. by Yvonne Schwarz (7406756)

“…(D) Maximum ΔF/F₀ from the data shown in (C), tko, <i>p</i> = 0.006; +C1, <i>p</i> = 0.0076; +C5, <i>p</i> = 0.0023. (E) TRPC deficiency decreases, whereas TRPC expression increases the slope of ΔF/F₀ during HFS (slope between the 6th and the 13th data point; tko, <i>p</i> = 0.003; +C1, <i>p</i> = 0.035; +C5, <i>p</i> = 0.002. …”

A novel SNP of <i>MYO1A</i> gene associated with heat-tolerance in Chinese cattle by Yanhong Cao (428443)

Data set. by Muriel Aldunate (22411177)

“…LA decreased HIV-1 virion-associated RNA levels by ∼50% compared to untreated virus (p < 0.001), acetic acid or HCl acidified media. …”

Virucidal activity of equimolar levels of the protonated form of vaginal LA, SCFAs, and succinic acid. by Muriel Aldunate (22411177)

Image_5_Photovoltaic panels have altered grassland plant biodiversity and soil microbial diversity.jpg by Zhenyin Bai (13878464)

CD44v6 is required for the growth of BTSC in CD44^high GBM. by Mayumi Jijiwa (207098)

“…B: Treatment with siRNA decreased the expression of CD44v6 in both neurosphere (left panel) and serum-propagated CD44^high GBM (middle panel). …”

Effects of Glu on NMDAR1 expression in cultured lungs. by Xiao-Hong Li (286234)

Frequencies of different behaviours (Compartment Changes, Escape Attempts, Stimulus Orientation, Stimulus Approach, Stimulus Contact, Grunting, Barking, Excretion), the minimum dis... by Sara Hintze (3216885)

Spatial expression pattern of proBcMF26a: GUS-GFP. by Meiling Lyu (767333)

“…<p>(A–L) Histochemical GUS assays of the T₂<i>Arabidopsis</i> transformed with pBGWFS7.0–proBcMF26a: GUS-GFP vector. …”

Renal GRK4 knockdown impacted Mas receptor phosphorylation and Its-induced renal function in SHRs. by Lin Chen (54305)

Data Sheet 7_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 6_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 1_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 3_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”

Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

“…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”